All eyes on Nvidia as it reports earnings this week. Does DeepSeek impact NVDA in any form? Wait and watch. US Q4 GDP's second estimate is due Friday. See more here.

State of New Jersey Common Pension Fund D decreased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free ...

Hims & Hers Health (NYSE:HIMS – Get Free Report) is projected to announce its earnings results after the market closes on ...

CNBC's Jim Cramer walked investors through next week on Wall Street and highlighted earnings reports from Home Depot as well ...

UnitedHealth Group is under investigation by the Justice Department **over its Medicare billing prac ...

Poor earnings results and a slump in the major gauges leave the weekend uncertain as futures hug the flatline.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food and Drug Administration (FDA) reported that the shortage of weight-loss drugs such as ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.

Investing.com - The S&P 500 slumped Friday, ending the week with a loss as soft data flagging worries about the economy triggered a sea of red of across stock. At 4:00 p.m. ET, the 30-stock Dow Jones ...